SHUENN-NAN CHIUMEI-HWAN WU2021-01-052021-01-0520180167-5273https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052145967&doi=10.1016%2fj.ijcard.2018.08.050&partnerID=40&md5=f35e0207fcbf074c74757f7732b4d44dhttps://scholars.lib.ntu.edu.tw/handle/123456789/538232[SDGs]SDG3brain natriuretic peptide; losartan; ramipril; renin; cardiovascular magnetic resonance; cardiovascular risk; disease association; disease course; disease severity; echocardiography; Editorial; exercise; Fallot tetralogy; fluid retention; follow up; groups by age; heart death; heart dilatation; heart ejection fraction; heart hemodynamics; heart left ventricle enddiastolic pressure; heart left ventricle enddiastolic volume; heart left ventricle endsystolic volume; heart left ventricle failure; heart repolarization; heart right ventricle failure; heart right ventricle function; heart right ventricle outflow tract obstruction; heart surgery; heart ventricle remodeling; heart ventricle septum defect; heart ventricle tachycardia; human; long term survival; oxidative stress; predictor variable; priority journal; pulmonary valve insufficiency; pulmonary valve replacement; pulmonary valve stenosis; randomized controlled trial (topic); renin angiotensin aldosterone system; sodium retention; tissue Doppler imaging; treatment outcome; valvular heart disease; vasoconstriction; Fallot tetralogy; Humans; Pulmonary Valve Insufficiency; Ramipril; Renin; Renin-Angiotensin System; Tetralogy of Falloteditorial10.1016/j.ijcard.2018.08.050301449932-s2.0-85052145967